自体脂肪移植在二期乳房再造中的安全性与疗效
该回顾性研究分析了157例(270侧乳房)接受即刻两期假体乳房再造(IBR)并在五年内行脂肪移植的患者,比较二期术中(IFG)与后期(DFG)脂肪移植的结局。结果显示IFG组并发症率更低(p=0.0331),需额外修整手术更少(p<0.001),且完成再造与修整的时间比DFG组早一年以上(p<0.001),多变量回归显示IFG与减少修整(p<0.001)和总脂肪移植次数(p=0.008)相关。
要点
- 二期术中行脂肪移植不增加总体并发症率,且并发症率低于后期移植。
- 二期术中脂肪移植可减少额外修整手术次数和总脂肪移植次数。
- 二期术中脂肪移植使患者完成再造和修整的时间提前一年以上。
核心结论
- 二期术中行脂肪移植不增加总体并发症率,可减少额外手术并缩短达到满意外观的时间。
研究设计与样本
- 回顾性队列研究,纳入157例(270侧乳房)接受即刻两期假体乳房再造并在2012-2016年间行脂肪移植的患者,按首次脂肪移植时机分为IFG组和DFG组。
主要发现
- IFG组并发症率低于DFG组(p=0.0331)。
- DFG组需要超过一次额外修整手术的患者更多(p<0.001)。
- IFG组完成再造和修整的时间比DFG组早一年以上(p<0.001)。
- 多变量回归显示IFG与减少修整手术相关(p<0.001),与减少总脂肪移植次数相关(p=0.008)。
临床怎么用
- 在假体乳房再造二期术中同期行脂肪移植可能减少后续修整手术并缩短疗程。
局限性
- 回顾性研究,样本来自单一机构,可能存在选择偏倚和混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients often pursue revisions following implant-based breast reconstruction (IBR) to achieve their desired result. Fat grafting is a popular choice for patients and can be performed at second stage reconstruction or at a future date as a revisionary surgery. We investigate the best time to fat graft in IBR by comparing the outcomes of patients who received fat grafting during implant placement with those who pursued fat grafting during a tertiary procedure. METHODS: We retrospectively reviewed the charts of 157 patients (270 breasts) who underwent immediate two-stage IBR and fat grafting over a five-year period (2012-2016) at our institution. Two cohorts were created based on timing of first fat grafting procedure: immediate (IFG) and delayed (DFG). Charts were reviewed for postoperative complications or revisions. RESULTS: Complication rates were lower when fat grafting was performed during the second stage (p = 0.0331). Patients in the DFG cohort required more than one additional revision (p < 0.001) until the completion of reconstruction. Patients in the IFG cohort completed their reconstruction and revisions more than one year earlier than the DFG cohort (p < 0.001). Multivariable regressions showed IFG to be associated with decreased revisions (p < 0.001) and total fat grafting procedures (p = 0.008). CONCLUSIONS: These results indicate that fat grafting at the second stage does not increase overall complication rates, require fewer additional surgeries, and enables patients to reach their desired aesthetic appearance in a shorter time frame. Fewer total surgeries translate not only to a more economical option but also obviate the risk of complications that come with additional surgeries.
引用
- Patel AA, Martin SA, Cheesborough JE, et al. The safety and efficacy of autologous fat grafting during second stage breast reconstruction. J Plast Reconstr Aesthet Surg. 2020. PMID: 33189618. doi:10.1016/j.bjps.2020.10.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。